Zimmer Biomet (NYSE:ZBH) today said it has appointed Wilfred van Zuilen as president of Europe, Middle East, Africa, and Dr. Nitin Goyal as chief science, technology, and innovation officer.
“It is an exciting time at Zimmer Biomet as we continue to build out our Executive Team to ensure we have the proven, strategic leadership in place to guide us through the third phase of our business transformation,” president and CEO Bryan Hanson said in a news release. “As an organization, we remain focused on developing our people, placing the right team members in the right roles and providing the tools and support needed to execute and drive our performance.”
Van Zuilen will be responsible for the marketing, sales and distribution of products and services in the EMEA region.
Before joining the company, van Zulien was the regional VP to Northwestern Europe at Medtronic. He has also held numerous leadership roles at Medtronic, Covidien, Novartis and Edwards Lifesciences.
“We’re thrilled to have Wilfred join the Zimmer Biomet team to help advance our Mission and drive forward our business in the EMEA region,” chief operating officer Ivan Tornos said. “His experience in medtech, coupled with his deep knowledge of the EMEA region’s business needs, make him the ideal candidate for this role.”
Nitin Goyal will oversee the advanced research, product development and innovation platforms in the newly created chief science, technology and innovation officer role. He will also have oversight of medical education, clinical affairs and healthcare provider collaboration.
Goyal is currently a practicing hip and knee reconstruction surgeon and previously served as chief medical officer and senior VP of innovation and digital care delivery at Rally Health, part of UnitedHealth Group’s Optum business.
“Dr. Goyal joins the Zimmer Biomet team at a time when we’re advancing our portfolio of seamlessly connected digital health and robotic technologies that are designed to deliver data-powered clinical insights throughout the surgical journey,” Tornos said. “His clinical experience and expertise in the digital transformation of musculoskeletal care make up the perfect skill set to help drive forward our business at this vital time in the company’s transformation.”
